Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?

Table 3 Survival data for the four cohorts

	Overall survival			p value	Progression-free survival			p value
	Median, months	1-year (%)	3-year (%)		Median, months	1-year (%)	3-year (%)
HCC (n = 9)	42 [7–44]	5 (74)	3 (59)	0.188	7 [3–14]	2 (27)	0 (0)	0.550
CCa (n = 4)	19 [15–NR]	3 (75)	0 (0)		10 [7–15]	1 (25)	0 (0)
GBC (n = 3)	8 [2–13]	1 (50)	0 (0)		2 [1–13]	1 (33)	0 (0)
PCa (n = 1)	15 [N/A]	1 (100)	0 (0)		15 [N/A]	1 (100)	0 (0)

HCC hepatocellular carcinoma, CCa cholangiocarcinoma, GBC gallbladder cancer, PCa pancreatic cancer, NR not reached